The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammerberg, C.
Right arrow Articles by Cooper, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammerberg, C.
Right arrow Articles by Cooper, K. D.

The Journal of Immunology, Vol 157, Issue 12 5254-5261, Copyright © 1996 by American Association of Immunologists


ARTICLES

Reversal of immunosuppression inducible through ultraviolet-exposed skin by in vivo anti-CD11b treatment

C Hammerberg, N Duraiswamy and KD Cooper
Department of Dermatology, University of Michigan, Ann Arbor 48109, USA.

In both human in vitro models and murine in vivo adoptive transfer studies, UV-induced class II MHC+ CD11b+ leukocytes that infiltrate the epidermis appear to mediate UV-induced immunosuppression. In the present study, their role is further probed using an anti-CD11b mAb (clone 5C6), which is effective in vivo in blocking CD11b+ monocyte/macrophage diapedesis into inflammatory lesions. A single exposure, low dose UV protocol (72 mJ/cm2) that resulted in tolerance only when dinitroflurobenzene was applied 48 h later through the UV- irradiated skin, but not through a distant non-UV-irradiated site, was used. In vivo anti-CD11b treatment in non-UV-irradiated mice did not block contact sensitivity responses. However, the ability to induce a primary contact sensitivity response was completely restored in UV- irradiated mice receiving anti-CD11b. This restoration was associated with partial restoration of papillary dermal class II MHC+ NLDC-145- cells. In vivo anti-CD11b treatment also blocked tolerance induction, which was associated with a 50% reduction in the infiltration of class II MHC+ CD11b+ Gr-1+ monocyte/macrophages into UV-irradiated skin. In addition, anti-CD11b treatment partially protected against epidermal UV injury, in that the epidermal structure was better preserved and the keratinocytes were less severely damaged. CD11b+ leukocytes may thus affect UV-irradiated skin through at least two mechanisms: 1) a class II MHC+ CD11b+ Gr-1+ monocyte/macrophage population inducing a state of tolerance to Ag(s) acquired in UV-irradiated skin, and 2) CD11b+ leukocytes capable of inflicting additional injury to both keratinocytes and constitutive APC damaged by UV photons.


This article has been cited by other articles:


Home page
BloodHome page
S. Noda, S. A. Aguirre, A. Bitmansour, J. M. Brown, T. E. Sparer, J. Huang, and E. S. Mocarski
Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination
Blood, January 1, 2006; 107(1): 30 - 38.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
W. Kolgen, M. van Meurs, M. Jongsma, H. van Weelden, C. A. F. M. Bruijnzeel-Koomen, E. F. Knol, W. A. van Vloten, J. Laman, and F. R. de Gruijl
Differential Expression of Cytokines in UV-B-Exposed Skin of Patients With Polymorphous Light Eruption: Correlation With Langerhans Cell Migration and Immunosuppression
Arch Dermatol, March 1, 2004; 140(3): 295 - 302.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
K. Takeda, N. Yamaguchi, H. Akiba, Y. Kojima, Y. Hayakawa, J. E. Tanner, T. J. Sayers, N. Seki, K. Okumura, H. Yagita, et al.
Induction of Tumor-specific T Cell Immunity by Anti-DR5 Antibody Therapy
J. Exp. Med., February 17, 2004; 199(4): 437 - 448.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhang, L. L. McCormick, S. R. Desai, C. Wu, and A. C. Gilliam
Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation
J. Immunol., March 15, 2002; 168(6): 3088 - 3098.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. K. Katiyar and H. Mukhtar
Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress
J. Leukoc. Biol., May 1, 2001; 69(5): 719 - 726.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
L. L. McCormick, Y. Zhang, E. Tootell, and A. C. Gilliam
Anti-TGF-{beta} Treatment Prevents Skin and Lung Fibrosis in Murine Sclerodermatous Graft-Versus-Host Disease: A Model for Human Scleroderma
J. Immunol., November 15, 1999; 163(10): 5693 - 5699.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. K. Katiyar, A. Challa, T. S. McCormick, K. D. Cooper, and H. Mukhtar
Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production
Carcinogenesis, November 1, 1999; 20(11): 2117 - 2124.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Zhuang, B. Wang, G. A. Shinder, G. M. Shivji, T. W. Mak, and D. N. Sauder
TNF Receptor p55 Plays a Pivotal Role in Murine Keratinocyte Apoptosis Induced by Ultraviolet B Irradiation
J. Immunol., February 1, 1999; 162(3): 1440 - 1447.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Yoshida, K. Kang, M. Berger, G. Chen, A. C. Gilliam, A. Moser, L. Wu, C. Hammerberg, and K. D. Cooper
Monocyte Induction of IL-10 and Down-Regulation of IL-12 by iC3b Deposited in Ultraviolet-Exposed Human Skin
J. Immunol., December 1, 1998; 161(11): 5873 - 5879.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Hammerberg, S. K. Katiyar, M. C. Carroll, and K. D. Cooper
Activated Complement Component 3 (C3) Is Required for Ultraviolet Induction of Immunosuppression and Antigenic Tolerance
J. Exp. Med., April 6, 1998; 187(7): 1133 - 1138.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.